Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Exclusion Criteria

• •1. Have inadequate intravenous access.
• •2. Have received antipyretic drug therapy within 2 hours before dosing.
• •3. Have any history of allergy or hypersensitivity to NSAIDs or aspirin.
• •4. Have received another investigational drug within the past 30 days.
• •5. Be otherwise unsuitable for the study, in the opinion of the Investigator.
• •6. Have a fever due to hyperthermia.
• •7. Pregnant or nursing.